Cancer Institute A national cancer institute
designated cancer center

Sarcoma Clinical Trials Open to New Patients

  • Targeted therapies for gastrointestinal stromal tumors (GIST) with tyrosine kinase inhibitors are an important focus. Newer drugs for GIST are currently being studied.
  • Clinical trials of anti-angiogenesis agents, which prevent delivery of blood to tumors, and hypoxia-activating agents, which starve tumors of oxygen, are available for several subtypes of sarcoma.
  • Both of these discuss soft tissue sarcomas

Stanford Medicine Resources:

Footer Links: